TY - JOUR AB - Ovarian cancer is a gynecological neoplasm that can be found in women, which, due to diagnostic difficulties, is often detected at advanced stages when treatment becomes a significant problem. Moreover, in a number of cases there is a cancer recurrence and resistance to standard chemotherapy treatment. It has been suggested that cancer stem cells (CSCs) that were not eradicated during therapy may be responsible for this. For this reason, effective therapeutic methods eliminating CSCs are being studied, such as therapy targeting CSCs markers. In addition, numerous studies have also drawn attention to the usefulness of CSCs markers in predicting disease progression and assessing patient's prognosis as well as their importance in the development of treatment resistance. The present review presented research on selected CSCs markers, which may be of significant prognostic and therapeutic importance in ovarian cancer. AD - Department of Immunology and Serology, Faculty of Pharmaceutical Sciences in Sosnowiec Medical University of Silesia, 40‑055 Katowice, Poland AU - Królewska-Daszczyńska,Patrycja AU - Wendlocha,Dominika AU - Smycz-Kubańska,Marta AU - Stępień,Sebastian AU - Mielczarek-Palacz,Aleksandra DA - 2022/12/01 DO - 10.3892/ol.2022.13585 IS - 6 JO - Oncol Lett KW - cancer stem cells ovarian cancer markers PY - 2022 SN - 1792-1074 1792-1082 SP - 465 ST - Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review) T2 - Oncology Letters TI - Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review) UR - https://doi.org/10.3892/ol.2022.13585 VL - 24 ER -